VMP 39684111000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Cefalexin 250mg tablets
BNF code 0501021L0AAAGAG
Virtual Therapeutic Moiety Cefalexin
Date identifier became valid 26 May 2021
Previous product identifier 323885000
Basis of preferred name pINN - Proposed International Non-proprietary Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Cefalexin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cefalexin 250mg tablets (A A H Pharmaceuticals Ltd)
Cefalexin 250mg tablets (Flynn Pharma Ltd)
Cefalexin 250mg tablets (Medihealth (Northern) Ltd)
Cefalexin 250mg tablets (Phoenix Healthcare Distribution Ltd)
Cefalexin 250mg tablets (Sigma Pharmaceuticals Plc)
Cefalexin 250mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Cefalexin 250mg tablets 100 tablet
Cefalexin 250mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_1.3.0_20230123000001, imported on 25th January 2023 at 03:52:49.